Assessment of the Professional Difficulties of Adult With Attention Deficit / Hyperactivity Disorder Patients (WORKTDA)

November 8, 2019 updated by: University Hospital, Strasbourg, France

Impact of Adult With Attention Deficit / Hyperactivity Disorder on Professional Activity, a Prospective Cohort Study

Attention Deficit/Hyperactivity Disorder (ADHD), which is common and well known in children, persists into adulthood in more than 60% of cases, with significant impact on quality of life. Professional domain is particularly impaired.

The investigators hypothesize that ADHD symptoms causes professional difficulties, on the emotional, cognitive, physical and relational levels.

The main objective of this study is to better characterize these professional difficulties at to follow-up these difficulties after one year. Difficulties will be assessed by questionnaires and semi-directive interview.

The secondary objective is to determine what factors modulate these difficulties and what compensation strategies are implemented to address the patients.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Strasbourg, France, 67091
        • Les Hôpitaux Universitaires de Strasbourg
        • Contact:
        • Principal Investigator:
          • Sébastien WEIBEL

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 62 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients who consulted at the psychiatric clinic of Strasbourg, aged 18 to 62, with a diagnosis of attention deficit disorder with or without hyperactivity assessed by a psychiatrist, and who have been in a working situation in the last 3 months.

Description

Inclusion criteria:

  • Patients aged 18 to 62 years
  • Diagnosis of attention deficit disorder with or without hyperactivity by a psychiatrist
  • No treatment for ADHD in childhood or adolescence
  • Patient who has been in a professional situation during the last 3 months

Exclusion criteria:

  • Patient on sick leave or unemployed for more than 3 months
  • Depressive episode in acute phase
  • Subject with a mobility project that prevents follow-up for 1 year (planned move)
  • Impossibility of providing the subject with informed information (subject in an emergency situation, difficulties in understanding the subject, mental retardation, illiteracy or insufficient command of the French language...)
  • Subject under the protection of justice
  • Subject under guardianship or curatorship

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
ADHD in professional activity
Adult ADHD patients in active employment at the time of inclusion or who were in employment within 3 months prior to inclusion
Other: questionnaires
answer questionnaires

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Work Limitations Questionnaire (WLQ-25)
Time Frame: 1 year
It is a questionnaire with 25 items exploring 4 distinct dimensions: time management, physical demands, mental interpersonal demands and output demands.
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maslach Burnout Inventory
Time Frame: 1 year
It is a questionnaire with 22 items exploring 3 distinct dimensions: emotional exhaustion, deshumanization and personal achievement at work
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Strasbourg, France

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

December 1, 2019

Primary Completion (Anticipated)

December 1, 2019

Study Completion (Anticipated)

December 1, 2021

Study Registration Dates

First Submitted

July 11, 2019

First Submitted That Met QC Criteria

July 11, 2019

First Posted (Actual)

July 15, 2019

Study Record Updates

Last Update Posted (Actual)

November 13, 2019

Last Update Submitted That Met QC Criteria

November 8, 2019

Last Verified

November 1, 2019

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 7482

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Attention Deficit Hyperactivity Disorder in Adults

Clinical Trials on questionnaires

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe